These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36304455)

  • 1. Immune-related SERPINA3 as a biomarker involved in diabetic nephropathy renal tubular injury.
    Fan Z; Gao Y; Jiang N; Zhang F; Liu S; Li Q
    Front Immunol; 2022; 13():979995. PubMed ID: 36304455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.
    Huang XR; Chen WY; Truong LD; Lan HY
    J Am Soc Nephrol; 2003 Jul; 14(7):1738-47. PubMed ID: 12819233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.
    Zheng JM; Yao GH; Cheng Z; Wang R; Liu ZH
    Diabetologia; 2012 Mar; 55(3):801-11. PubMed ID: 22130579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The landscape of immune cell infiltration in the glomerulus of diabetic nephropathy: evidence based on bioinformatics.
    Zhou W; Liu Y; Hu Q; Zhou J; Lin H
    BMC Nephrol; 2022 Sep; 23(1):303. PubMed ID: 36064366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of potential key ferroptosis-related genes involved in tubulointerstitial injury in patients with diabetic nephropathy.
    Ma LL; Bai Y; Liu WH; Diao ZL
    Ren Fail; 2023 Dec; 45(1):2199095. PubMed ID: 37038746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
    Su K; Yi B; Yao BQ; Xia T; Yang YF; Zhang ZH; Chen C
    Pharmacol Res; 2020 Jun; 156():104778. PubMed ID: 32247822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium.
    Levin A; Reznichenko A; Witasp A; Liu P; Greasley PJ; Sorrentino A; Blondal T; Zambrano S; Nordström J; Bruchfeld A; Barany P; Ebefors K; Erlandsson F; Patrakka J; Stenvinkel P; Nyström J; Wernerson A
    Nephrol Dial Transplant; 2020 Dec; 35(12):2059-2072. PubMed ID: 32853351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
    Gui H; Chen X; Ye L; Ma H
    Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Verification of Diagnostic Biomarkers for Glomerular Injury in Diabetic Nephropathy Based on Machine Learning Algorithms.
    Han H; Chen Y; Yang H; Cheng W; Zhang S; Liu Y; Liu Q; Liu D; Yang G; Li K
    Front Endocrinol (Lausanne); 2022; 13():876960. PubMed ID: 35663304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy.
    Zhou H; Mu L; Yang Z; Shi Y
    Front Immunol; 2023; 14():1113212. PubMed ID: 36969169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased chymase-positive mast cells in children with crescentic glomerulonephritis.
    Togawa H; Nakanishi K; Shima Y; Obana M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2009 May; 24(5):1071-5. PubMed ID: 19050935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
    Kang WL; Xu GS
    Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The decreased expression of electron transfer flavoprotein β is associated with tubular cell apoptosis in diabetic nephropathy.
    Wang H; Zhang H; Chen X; Zhao T; Kong Q; Yan M; Zhang B; Sun S; Lan HY; Li N; Li P
    Int J Mol Med; 2016 May; 37(5):1290-8. PubMed ID: 27035869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin-induced renal local complement activation is involved in tubular interstitial injury in diabetic nephropathy.
    Zheng JM; Ren XG; Jiang ZH; Chen DJ; Zhao WJ; Li LJ
    Clin Chim Acta; 2018 Jul; 482():65-73. PubMed ID: 29604259
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Wang X; Li R; Liu T; Jia Y; Gao X; Zhang X
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):294-303. PubMed ID: 35713142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EP300 promotes renal tubular epithelial cell fibrosis by increasing HIF2α expression in diabetic nephropathy.
    Gong Y; Dou Y; Wang L; Wang X; Zhao Z
    Cell Signal; 2022 Oct; 98():110407. PubMed ID: 35839978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Biomarkers Related to Th17 Cells in Macular Edema of Diabetic Retinopathy: Cutting-Edge Comprehensive Bioinformatics Analysis and
    Huang J; Zhou Q
    Front Immunol; 2022; 13():858972. PubMed ID: 35651615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysine 63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy.
    Pontrelli P; Oranger A; Barozzino M; Divella C; Conserva F; Fiore MG; Rossi R; Papale M; Castellano G; Simone S; Laviola L; Giorgino F; Piscitelli D; Gallone A; Gesualdo L
    J Mol Med (Berl); 2018 Jul; 96(7):645-659. PubMed ID: 29806072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.